Metabolites of the gut microbiota may serve as precise diagnostic markers for sarcopenia in the elderly
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Random forest models were trained on shotgun metagenomic species and fecal-metabolite features for 32 sarcopenia and 31 control participants. Methods specify fivefold cross-validation and 50/50 train-test evaluation; species-model AUC varied 0.7083–0.8833 across three random validations. This supports exploratory classification in a small cross-sectional cohort, not clinical deployment or causal microbiome claims.
Technology: Random forest models were trained on shotgun metagenomic species and fecal-metabolite features for 32 sarcopenia and 31 control participants. Methods specify fivefold cross-validation and 50/50 train-test evaluation.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Random forest models were trained on shotgun metagenomic species and fecal-metabolite features for 32 sarcopenia and 31 control participants. Methods specify fivefold cross-validation and 50/50 train-test evaluation.
- Limitation / still unknown
- The result is limited to the reported dataset, experimental setting and validation in this study; broader generalization and real-world benefit are not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2023.1301805/full · https://pubmed.ncbi.nlm.nih.gov/38188577/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.